TY - CHAP M1 - Book, Section TI - Leishmaniasis A1 - Rosenthal, Philip J. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. Y1 - 2023 N1 - T2 - Current Medical Diagnosis & Treatment 2023 AB - Key Clinical Updates in LeishmaniasisAlternative therapies increasingly used to treat cutaneous leishmaniasis are miltefosine, which benefits from oral dosing and relatively little toxicity, and amphotericin B, which is widely available.Machado PRL et al. Clin Infect Dis. [PMID: 32894278] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/11/12 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193137663 ER -